Fobi AI Provides Clarification On Total Holdings Previously Provided In The Companys Information Circular
December 06, 2024 20:43 ET | Source: Fobi AI Inc. VANCOUVER, British…
Fobi AI Provides Update on Current Cease Trade Order
December 06, 2024 20:34 ET | Source: Fobi AI Inc. VANCOUVER, British…
Voxtur Announces Amendments to Financial Statements and MD&A forQ3 Ended September 30, 2024
December 06, 2024 18:16 ET | Source: Voxtur Analytics Corp. TORONTO and…
Cerence AI Announces Equity Grant to Employee Under Inducement Plan Pursuant to Nasdaq Listing Rule 5635(c)(4)
BURLINGTON, Mass., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC)…
VivoPower to host Annual General Meeting on December 30, 2024 in London
London, Dec. 06, 2024 (GLOBE NEWSWIRE) -- VivoPower International PLC (NASDAQ: VVPR)…
Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Associations 35th International Symposium on ALS/MND
BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ:…
Zevra Therapeutics Announces Organizational Changes
December 06, 2024 17:00 ET | Source: Zevra Therapeutics CELEBRATION, Fla., Dec.…
BioAge Labs Announces Discontinuation of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag in Combination with Tirzepatide for the Treatment of Obesity
December 06, 2024 16:35 ET | Source: BioAge Labs, Inc. Decision follows…
M3 Group Joins MEDIROM Mother Labs Series A Financing Round at JPY9 Billion (as of December 1, 2024, approximately USD $59,000,000) Pre-Money Valuation
TOKYO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ:…
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 06, 2024 16:30 ET | Source: Tempest Therapeutics BRISBANE, Calif., Dec.…
